522629-08-9,MFCD03861062
Catalog No.:AA00DA6V

522629-08-9 | CGP-57380

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98+%
in stock  
$25.00   $18.00
- +
5mg
98+%
in stock  
$64.00   $45.00
- +
10mg
98+%
in stock  
$94.00   $66.00
- +
50mg
98+%
in stock  
$270.00   $189.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00DA6V
Chemical Name:
CGP-57380
CAS Number:
522629-08-9
Molecular Formula:
C11H9FN6
Molecular Weight:
244.2278
MDL Number:
MFCD03861062
SMILES:
Fc1ccc(cc1)Nc1n[nH]c2c1c(N)ncn2
NSC Number:
741567
Properties
Computed Properties
 
Complexity:
283  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.3  

Literature

Title: Phosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T: A Rationale for Novel Therapeutic Approaches.

Journal: PloS one 20150101

Title: A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.

Journal: The Biochemical journal 20130415

Title: MNK1 expression increases during cellular senescence and modulates the subcellular localization of hnRNP A1.

Journal: Experimental cell research 20120310

Title: Targeting Mnks for cancer therapy.

Journal: Oncotarget 20120201

Title: Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.

Journal: Nature biotechnology 20111101

Title: Identification of new inhibitors of protein kinase R guided by statistical modeling.

Journal: Bioorganic & medicinal chemistry letters 20110701

Title: MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.

Journal: Cancer research 20110315

Title: Mnk mediates integrin α6β4-dependent eIF4E phosphorylation and translation of VEGF mRNA.

Journal: Molecular cancer research : MCR 20101201

Title: The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival.

Journal: Cancer biology & therapy 20101001

Title: Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.

Journal: Journal of medicinal chemistry 20100923

Title: Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases.

Journal: Experimental dermatology 20080601

Title: Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.

Journal: The Journal of biological chemistry 20080502

Title: MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages.

Journal: American journal of physiology. Gastrointestinal and liver physiology 20080201

Title: The selectivity of protein kinase inhibitors: a further update.

Journal: The Biochemical journal 20071215

Title: Loss of MNK function sensitizes fibroblasts to serum-withdrawal induced apoptosis.

Journal: Genes to cells : devoted to molecular & cellular mechanisms 20071001

Title: Shiga toxin 1-induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage-like THP-1 cell line.

Journal: Journal of leukocyte biology 20060201

Title: Adenovirus-induced extracellular signal-regulated kinase phosphorylation during the late phase of infection enhances viral protein levels and virus progeny.

Journal: Cancer research 20060201

Title: Posttranscriptional regulation of TNFalpha expression via eukaryotic initiation factor 4E (eIF4E) phosphorylation in mouse macrophages.

Journal: Cytokine 20060107

Title: Shiga toxins activate translational regulation pathways in intestinal epithelial cells.

Journal: Cellular signalling 20050701

Title: Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).

Journal: The Biochemical journal 20050615

Title: Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.

Journal: Cancer research 20041201

Title: Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells.

Journal: Circulation research 20031212

Title: Phosphorylation of initiation factor 4E is resistant to SB203580 in cells expressing a drug-resistant mutant of stress-activated protein kinase 2a/p38.

Journal: Cellular signalling 20030801

Title: Phosphorylation of eukaryotic initiation factor (eIF) 4E is not required for de novo protein synthesis following recovery from hypertonic stress in human kidney cells.

Journal: The Journal of biological chemistry 20020906

Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

Journal: The Journal of biological chemistry 20020419

Title: Knauf U, et al. Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2. Mol Cell Biol. 2001 Aug;21(16):5500-11.

Title: Ishida M, et al. Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells. Circ Res. 2003 Dec 12;93(12):1218-24. Epub 2003 Nov 6

Title: Chrestensen CA, et al. Loss of MNK function sensitizes fibroblasts to serum-withdrawal induced apoptosis. Genes Cells. 2007 Oct;12(10):1133-40.

Title: Lim S, et al. Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function. Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):E2298-307

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 522629-08-9
Tags:522629-08-9 Molecular Formula|522629-08-9 MDL|522629-08-9 SMILES|522629-08-9 CGP-57380
Catalog No.: AA00DA6V
522629-08-9,MFCD03861062
522629-08-9 | CGP-57380
Pack Size: 1mg
Purity: 98+%
in stock
$25.00 $18.00
Pack Size: 5mg
Purity: 98+%
in stock
$64.00 $45.00
Pack Size: 10mg
Purity: 98+%
in stock
$94.00 $66.00
Pack Size: 50mg
Purity: 98+%
in stock
$270.00 $189.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00DA6V
Chemical Name: CGP-57380
CAS Number: 522629-08-9
Molecular Formula: C11H9FN6
Molecular Weight: 244.2278
MDL Number: MFCD03861062
SMILES: Fc1ccc(cc1)Nc1n[nH]c2c1c(N)ncn2
NSC Number: 741567
Properties
Complexity: 283  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 3  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.3  
Literature fold

Title: Phosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T: A Rationale for Novel Therapeutic Approaches.

Journal: PloS one20150101

Title: A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.

Journal: The Biochemical journal20130415

Title: MNK1 expression increases during cellular senescence and modulates the subcellular localization of hnRNP A1.

Journal: Experimental cell research20120310

Title: Targeting Mnks for cancer therapy.

Journal: Oncotarget20120201

Title: Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.

Journal: Nature biotechnology20111101

Title: Identification of new inhibitors of protein kinase R guided by statistical modeling.

Journal: Bioorganic & medicinal chemistry letters20110701

Title: MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.

Journal: Cancer research20110315

Title: Mnk mediates integrin α6β4-dependent eIF4E phosphorylation and translation of VEGF mRNA.

Journal: Molecular cancer research : MCR20101201

Title: The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival.

Journal: Cancer biology & therapy20101001

Title: Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.

Journal: Journal of medicinal chemistry20100923

Title: Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases.

Journal: Experimental dermatology20080601

Title: Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.

Journal: The Journal of biological chemistry20080502

Title: MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages.

Journal: American journal of physiology. Gastrointestinal and liver physiology20080201

Title: The selectivity of protein kinase inhibitors: a further update.

Journal: The Biochemical journal20071215

Title: Loss of MNK function sensitizes fibroblasts to serum-withdrawal induced apoptosis.

Journal: Genes to cells : devoted to molecular & cellular mechanisms20071001

Title: Shiga toxin 1-induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage-like THP-1 cell line.

Journal: Journal of leukocyte biology20060201

Title: Adenovirus-induced extracellular signal-regulated kinase phosphorylation during the late phase of infection enhances viral protein levels and virus progeny.

Journal: Cancer research20060201

Title: Posttranscriptional regulation of TNFalpha expression via eukaryotic initiation factor 4E (eIF4E) phosphorylation in mouse macrophages.

Journal: Cytokine20060107

Title: Shiga toxins activate translational regulation pathways in intestinal epithelial cells.

Journal: Cellular signalling20050701

Title: Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).

Journal: The Biochemical journal20050615

Title: Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.

Journal: Cancer research20041201

Title: Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells.

Journal: Circulation research20031212

Title: Phosphorylation of initiation factor 4E is resistant to SB203580 in cells expressing a drug-resistant mutant of stress-activated protein kinase 2a/p38.

Journal: Cellular signalling20030801

Title: Phosphorylation of eukaryotic initiation factor (eIF) 4E is not required for de novo protein synthesis following recovery from hypertonic stress in human kidney cells.

Journal: The Journal of biological chemistry20020906

Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

Journal: The Journal of biological chemistry20020419

Title: Knauf U, et al. Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2. Mol Cell Biol. 2001 Aug;21(16):5500-11.

Title: Ishida M, et al. Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells. Circ Res. 2003 Dec 12;93(12):1218-24. Epub 2003 Nov 6

Title: Chrestensen CA, et al. Loss of MNK function sensitizes fibroblasts to serum-withdrawal induced apoptosis. Genes Cells. 2007 Oct;12(10):1133-40.

Title: Lim S, et al. Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function. Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):E2298-307

Building Blocks More >
4810-41-7
4810-41-7
N,N-Dimethylpyridine-3-sulfonamide
AA00DA9R | MFCD07368248
54502-37-3
54502-37-3
2-Ethylbutanoic anhydride
AA00DAD8 | MFCD00042894
51984-71-5
51984-71-5
Ethyl 2-methyl-5-nitronicotinate
AA00DAM7 | MFCD00753850
436096-46-7
436096-46-7
2,7,8-Trimethyl-4-quinolinecarboxylic acid
AA00DAQY | MFCD28024644
54384-06-4
54384-06-4
N-Me-gly-obzl p-tosylate
AA00DAVN | MFCD00191015
436133-68-5
436133-68-5
Kobe-0065
AA00DB3O | MFCD04109603
50411-26-2
50411-26-2
1-Amino-3-phenylpropan-2-ol
AA00DB7A | MFCD03840182
500728-34-7
500728-34-7
2,5-Dimethyl-1-(2-methylphenyl)-1h-pyrrole-3-carboxylic acid
AA00DBC1 | MFCD03988001
53348-05-3
53348-05-3
3,6-Dibromo-phenanthrenequinone
AA00DBHZ | MFCD00451676
55290-86-3
55290-86-3
4-Iodo-4'-methylbiphenyl
AA00DBOW | MFCD00457077
Submit
© 2017 AA BLOCKS, INC. All rights reserved.